Bodal Chemicals Ltd

Bodal Chemicals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bodal Chemicals Ltd

₹ 73.0 -1.14%
06 Jun - close price
bodal.com BSE: 524370 NSE: BODALCHEM
About

Bodal Chemicals Limited is one of India’s leading integrated Dyestuff companies and is the largest domestic manufacturer of Dye Intermediates. It offers a wide range of Dyestuffs, Dye Intermediates, Basic Chemicals, and its variants to diverse customers across India and the world. [1]

Key Points

Product Portfolio (200+ products)[1]
Basic Chemicals (12 products)
Dye Intermediates (25 products)
Dyestuffs (175 products)
Chlor Alkali (6 products)
New Product Addition: Benzene Derivatives (5 products)

Website BSE NSE
  • Market Cap ₹ 919 Cr.
  • Current Price ₹ 73.0
  • High / Low ₹ 88.0 / 49.6
  • Stock P/E 44.8
  • Book Value ₹ 91.5
  • Dividend Yield 0.00 %
  • ROCE 5.27 %
  • ROE 1.79 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Stock is trading at 0.80 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 7.09% over past five years.
  • Company has a low return on equity of 1.55% over last 3 years.
  • Dividend payout has been low at 1.35% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Dyes And Pigments

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
590 448 405 309 389 326 328 337 396 420 423 435 446
534 407 373 286 364 302 305 314 357 383 390 389 396
Operating Profit 56 41 31 23 26 24 22 24 38 38 32 46 50
OPM % 9% 9% 8% 7% 7% 7% 7% 7% 10% 9% 8% 11% 11%
-0 1 1 2 4 4 6 5 1 1 5 0 2
Interest 6 7 6 10 11 11 13 12 16 20 20 20 20
Depreciation 12 12 12 14 14 14 14 14 17 17 17 17 17
Profit before tax 38 23 14 2 4 1 1 2 7 2 1 10 15
Tax % 24% 26% 27% 5% 41% 26% 31% 62% 30% 25% 25% 25% 28%
29 17 10 1 2 1 1 1 5 1 1 7 11
EPS in Rs 2.35 1.41 0.84 0.12 0.17 0.09 0.08 0.06 0.39 0.09 0.05 0.58 0.84
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
960 1,043 907 1,182 1,121 1,379 1,224 1,130 2,011 1,555 1,386 1,723
770 859 758 961 924 1,146 1,091 1,047 1,787 1,434 1,279 1,557
Operating Profit 189 184 150 221 197 233 133 83 224 121 108 166
OPM % 20% 18% 17% 19% 18% 17% 11% 7% 11% 8% 8% 10%
-70 5 20 15 12 15 14 18 8 8 15 8
Interest 47 27 12 7 5 7 14 9 21 34 52 80
Depreciation 25 22 26 26 11 18 26 28 46 52 60 68
Profit before tax 47 139 132 203 193 222 106 64 165 43 12 27
Tax % 35% 34% 34% 35% 34% 35% 15% 24% 25% 27% 35% 26%
31 92 87 133 128 144 90 48 124 31 8 20
EPS in Rs 2.81 8.43 7.94 12.18 10.44 11.79 7.37 3.95 10.15 2.48 0.61 1.55
Dividend Payout % 0% 0% 8% 7% 8% 7% 11% 20% 8% 4% 0% 0%
Compounded Sales Growth
10 Years: 5%
5 Years: 7%
3 Years: -5%
TTM: 24%
Compounded Profit Growth
10 Years: -14%
5 Years: -26%
3 Years: -45%
TTM: 1276%
Stock Price CAGR
10 Years: 11%
5 Years: 5%
3 Years: -9%
1 Year: 2%
Return on Equity
10 Years: 10%
5 Years: 4%
3 Years: 2%
Last Year: 2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 22 22 22 22 24 24 24 24 24 25 25 25
Reserves 47 139 218 341 678 811 912 968 1,078 1,101 1,108 1,127
397 234 143 142 148 135 238 436 640 755 903 911
132 145 132 187 191 265 249 279 384 281 300 333
Total Liabilities 597 539 514 692 1,041 1,235 1,424 1,708 2,127 2,163 2,336 2,396
168 190 184 196 412 529 613 760 804 955 1,302 1,291
CWIP 8 3 0 9 14 20 1 4 70 193 68 61
Investments 2 3 3 21 24 20 41 44 99 100 113 101
419 343 326 465 591 666 770 899 1,155 914 852 943
Total Assets 597 539 514 692 1,041 1,235 1,424 1,708 2,127 2,163 2,336 2,396

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
49 198 133 112 22 210 65 -22 30 246 191 106
-21 -35 -24 -100 -216 -175 -146 -171 -194 -315 -266 -39
-27 -162 -109 -9 191 -29 86 186 162 69 88 -71
Net Cash Flow 1 0 -1 3 -3 6 6 -6 -2 1 14 -5

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 86 69 67 56 89 77 111 128 98 95 99 84
Inventory Days 72 43 56 57 58 77 90 126 141 112 128 134
Days Payable 66 62 67 75 77 80 92 101 83 76 101 98
Cash Conversion Cycle 92 50 56 39 70 74 109 152 155 131 126 120
Working Capital Days 89 66 75 62 113 81 117 158 129 135 132 122
ROCE % 39% 39% 35% 46% 29% 25% 11% 6% 11% 4% 3% 5%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
58.94% 58.87% 57.47% 57.47% 57.39% 57.39% 57.39% 57.39% 57.39% 57.32% 57.32% 57.32%
3.06% 3.09% 2.42% 2.43% 2.37% 0.45% 0.30% 0.77% 0.19% 0.67% 0.32% 0.32%
0.17% 0.16% 0.16% 0.14% 0.01% 0.03% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
37.82% 37.88% 39.94% 39.97% 40.22% 42.12% 42.29% 41.82% 42.41% 42.00% 42.36% 42.35%
No. of Shareholders 59,67963,24764,22564,79566,07377,81676,86777,33277,49581,42078,83178,163

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls